Waracharee Srifa

1.0k total citations
9 papers, 539 citations indexed

About

Waracharee Srifa is a scholar working on Molecular Biology, Genetics and Oncology. According to data from OpenAlex, Waracharee Srifa has authored 9 papers receiving a total of 539 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Molecular Biology, 4 papers in Genetics and 2 papers in Oncology. Recurrent topics in Waracharee Srifa's work include CRISPR and Genetic Engineering (5 papers), Mesenchymal stem cell research (3 papers) and Virus-based gene therapy research (2 papers). Waracharee Srifa is often cited by papers focused on CRISPR and Genetic Engineering (5 papers), Mesenchymal stem cell research (3 papers) and Virus-based gene therapy research (2 papers). Waracharee Srifa collaborates with scholars based in United States, Ireland and Israel. Waracharee Srifa's co-authors include Matthew H. Porteus, Ciaran M. Lee, Gang Bao, Joab Camarena, Michèle P. Calos, Soeren Turan, John Day, Sruthi Mantri, Volker Wiebking and Geoffrey C. Gurtner and has published in prestigious journals such as Nucleic Acids Research, Nature Communications and Nature Biotechnology.

In The Last Decade

Waracharee Srifa

9 papers receiving 533 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Waracharee Srifa United States 8 386 164 93 79 74 9 539
Moonsup Jeong South Korea 9 253 0.7× 120 0.7× 157 1.7× 67 0.8× 37 0.5× 16 471
Zhen Yan China 14 296 0.8× 31 0.2× 109 1.2× 93 1.2× 59 0.8× 44 610
Asitha Gurusinghe Australia 10 440 1.1× 233 1.4× 35 0.4× 44 0.6× 158 2.1× 12 652
Romain Barbet France 10 384 1.0× 228 1.4× 116 1.2× 20 0.3× 63 0.9× 16 614
Azam Rahimpour Iran 16 380 1.0× 75 0.5× 32 0.3× 26 0.3× 26 0.4× 45 666
Diana D. Kang United States 15 540 1.4× 95 0.6× 19 0.2× 29 0.4× 65 0.9× 25 853
Jingchun Liu United States 14 142 0.4× 65 0.4× 64 0.7× 63 0.8× 20 0.3× 30 613
Jorge L. Santiago-Ortiz United States 8 293 0.8× 210 1.3× 21 0.2× 34 0.4× 16 0.2× 9 473
Brian Lee United States 13 457 1.2× 45 0.3× 65 0.7× 47 0.6× 15 0.2× 26 658
Seung Shin Yu South Korea 13 271 0.7× 192 1.2× 35 0.4× 32 0.4× 28 0.4× 21 452

Countries citing papers authored by Waracharee Srifa

Since Specialization
Citations

This map shows the geographic impact of Waracharee Srifa's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Waracharee Srifa with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Waracharee Srifa more than expected).

Fields of papers citing papers by Waracharee Srifa

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Waracharee Srifa. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Waracharee Srifa. The network helps show where Waracharee Srifa may publish in the future.

Co-authorship network of co-authors of Waracharee Srifa

This figure shows the co-authorship network connecting the top 25 collaborators of Waracharee Srifa. A scholar is included among the top collaborators of Waracharee Srifa based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Waracharee Srifa. Waracharee Srifa is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

9 of 9 papers shown
1.
Mencía, Ángeles, Waracharee Srifa, Sriram Vaidyanathan, et al.. (2021). Correction of recessive dystrophic epidermolysis bullosa by homology-directed repair-mediated genome editing. Molecular Therapy. 29(6). 2008–2018. 31 indexed citations
2.
Wiebking, Volker, James O. Patterson, Renata M. Martin, et al.. (2020). Metabolic engineering generates a transgene-free safety switch for cell therapy. Nature Biotechnology. 38(12). 1441–1450. 32 indexed citations
3.
Kosaric, Nina, Waracharee Srifa, Clark A. Bonham, et al.. (2020). Macrophage Subpopulation Dynamics Shift following Intravenous Infusion of Mesenchymal Stromal Cells. Molecular Therapy. 28(9). 2007–2022. 18 indexed citations
4.
Srifa, Waracharee, Nina Kosaric, Sruthi Mantri, et al.. (2020). Cas9-AAV6-engineered human mesenchymal stromal cells improved cutaneous wound healing in diabetic mice. Nature Communications. 11(1). 2470–2470. 61 indexed citations
5.
Pavel-Dinu, Mara, Volker Wiebking, Beruh Dejene, et al.. (2019). Gene correction for SCID-X1 in long-term hematopoietic stem cells. Nature Communications. 10(1). 1634–1634. 135 indexed citations
6.
Park, So Hyun, Ciaran M. Lee, Daniel P. Dever, et al.. (2019). Highly efficient editing of the β-globin gene in patient-derived hematopoietic stem and progenitor cells to treat sickle cell disease. Nucleic Acids Research. 47(15). 7955–7972. 110 indexed citations
7.
Forche, Anja, Gareth A. Cromie, Aleeza C. Gerstein, et al.. (2018). Rapid Phenotypic and Genotypic Diversification After Exposure to the Oral Host Niche in Candida albicans. Genetics. 209(3). 725–741. 73 indexed citations
8.
Kosaric, Nina, Waracharee Srifa, Geoffrey C. Gurtner, & Matthew H. Porteus. (2017). Abstract 100: Human Mesenchymal Stromal Cells Engineered to Overexpress PDGF-B Using CRISPR/Cas9/rAAV6-based Tools Improve Wound Healing. Plastic & Reconstructive Surgery Global Open. 5(4S). 74–74. 6 indexed citations
9.
Turan, Soeren, et al.. (2016). Precise Correction of Disease Mutations in Induced Pluripotent Stem Cells Derived From Patients With Limb Girdle Muscular Dystrophy. Molecular Therapy. 24(4). 685–696. 73 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026